258 related articles for article (PubMed ID: 19075676)
21. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
22. Detection of minor subpopulations of colorectal adenocarcinoma cells expressing cancer stem cell markers.
Gisina AM; Lupatov AY; Karalkin PA; Mainovskaya OA; Petrov LO; Sidorov DV; Yarygin VN; Yarygin KN
Bull Exp Biol Med; 2011 Jun; 151(2):234-8. PubMed ID: 22238758
[TBL] [Abstract][Full Text] [Related]
23. Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
Ohara Y; Oda T; Sugano M; Hashimoto S; Enomoto T; Yamada K; Akashi Y; Miyamoto R; Kobayashi A; Fukunaga K; Morishita Y; Ohkohchi N
Cancer Sci; 2013 Aug; 104(8):1127-34. PubMed ID: 23679813
[TBL] [Abstract][Full Text] [Related]
24. Lessons from common markers of tumor-initiating cells in solid cancers.
Gires O
Cell Mol Life Sci; 2011 Dec; 68(24):4009-22. PubMed ID: 21786143
[TBL] [Abstract][Full Text] [Related]
25. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
26. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
[TBL] [Abstract][Full Text] [Related]
27. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
28. EpCAM expression in the prostate cancer makes the difference in the response to growth factors.
Yoshida GJ; Saya H
Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103
[TBL] [Abstract][Full Text] [Related]
29. Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability.
Guo C; Liu H; Zhang BH; Cadaneanu RM; Mayle AM; Garraway IP
PLoS One; 2012; 7(4):e34219. PubMed ID: 22514625
[TBL] [Abstract][Full Text] [Related]
30. Exosomes in Cancer Disease.
Zöller M
Methods Mol Biol; 2016; 1381():111-49. PubMed ID: 26667458
[TBL] [Abstract][Full Text] [Related]
31. More than markers: biological significance of cancer stem cell-defining molecules.
Keysar SB; Jimeno A
Mol Cancer Ther; 2010 Sep; 9(9):2450-7. PubMed ID: 20716638
[TBL] [Abstract][Full Text] [Related]
32. Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines.
Gadalla SE; Alexandraki A; Lindström MS; Nistér M; Ericsson C
Biochem Biophys Res Commun; 2011 Feb; 405(4):581-7. PubMed ID: 21266162
[TBL] [Abstract][Full Text] [Related]
33. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
[TBL] [Abstract][Full Text] [Related]
34. CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma.
Hoe SLL; Tan LP; Abdul Aziz N; Liew K; Teow SY; Abdul Razak FR; Chin YM; Mohamed Shahrehan NA; Chu TL; Mohd Kornain NK; Peh SC; Koay CE; Lo KW; Ahmad M; Ng CC; Khoo AS
Sci Rep; 2017 Sep; 7(1):12372. PubMed ID: 28959019
[TBL] [Abstract][Full Text] [Related]
35. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
[TBL] [Abstract][Full Text] [Related]
36. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
[TBL] [Abstract][Full Text] [Related]
37. EpCAM and its potential role in tumor-initiating cells.
Imrich S; Hachmeister M; Gires O
Cell Adh Migr; 2012; 6(1):30-8. PubMed ID: 22647938
[TBL] [Abstract][Full Text] [Related]
38. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
39. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
Patriarca C; Macchi RM; Marschner AK; Mellstedt H
Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
[TBL] [Abstract][Full Text] [Related]
40. Macrophage-tumor cell fusions from peripheral blood of melanoma patients.
Clawson GA; Matters GL; Xin P; Imamura-Kawasawa Y; Du Z; Thiboutot DM; Helm KF; Neves RI; Abraham T
PLoS One; 2015; 10(8):e0134320. PubMed ID: 26267609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]